{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:55:26Z","timestamp":1790420126805,"version":"4.1.0"},"reference-count":19,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2008,9]]},"abstract":"<jats:p>\n                    <jats:bold>BACKGROUND:<\/jats:bold>\n                    Drug\u2010induced immune hemolytic anemia (DIIHA) is a well\u2010known complication of drug treatment. Sensitization can occur, due to interaction of the drug and\/or its metabolites with cells of the immune system, after the first drug administration, while the hemolytic crisis generally occurs after repeated administration of a drug. This event occurred in the case described here of acute hemolysis due to the administration of corticosteroids.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>STUDY DESIGN AND METHODS:<\/jats:bold>\n                    To define the etiopathogenesis of the hemolytic crisis, immunohematologic screening and specific tests were performed to identify antibodies against a possible drug\u2013red cell (RBC) complex and circulating drug\u2013anti\u2010drug antibody immune complexes. Six drugs administered to the patient were tested and results were confirmed by test repetition using other types of corticosteroids.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>RESULTS:<\/jats:bold>\n                    Indirect antiglobulin test performed with the patient's serum sample on 22 RBC samples from commercial panels was strongly positive, while it was negative on RBCs from ABO\u2010compatible donors. The same test repeated on commercial RBCs after washing was negative. Specific tests were negative for five of the six tested drugs, while RBCs incubated with hydrocortisone strongly reacted with the patient's serum. The same tests performed using other types of corticosteroids confirmed a reaction with the same positivity score on all tested molecules.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>CONCLUSION:<\/jats:bold>\n                    The positive reaction observed each time the patient's serum sample was incubated with RBCs in the presence of corticosteroids suggested that the triggering cause of hemolysis was an immune\u2010mediated mechanism and the drug responsible for DIIHA was hydrocortisone.\n                  <\/jats:p>","DOI":"10.1111\/j.1537-2995.2008.01797.x","type":"journal-article","created":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T18:12:57Z","timestamp":1220292777000},"page":"1925-1929","source":"Crossref","is-referenced-by-count":7,"title":["The first case of drug\u2010induced immune hemolytic anemia due to hydrocortisone"],"prefix":"10.1111","volume":"48","author":[{"given":"Marina","family":"Martinengo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego Fabio","family":"Ardenghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gino","family":"Tripodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Reali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,9]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1182\/blood.V69.4.1006.1006","article-title":"On the mechanism of sensitization and attachment of antibodies to RBC in drug\u2010induced immune hemolytic anemia","volume":"69","author":"Salama A","year":"1987","journal-title":"Blood"},{"key":"e_1_2_7_3_2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.21307\/immunohematology-2019-1075","article-title":"Current viewpoints on mechanisms causing drug\u2010induced immune hemolytic anemia and\/or positive direct antiglobulin tests","volume":"5","author":"Garratty G","year":"1989","journal-title":"Immonohematology"},{"key":"e_1_2_7_4_2","volume-title":"Acquired immune hemolytic anemias","author":"Petz LD","year":"1980"},{"key":"e_1_2_7_5_2","first-page":"523","volume-title":"Immunobiology of transfusion medicine","author":"Garratty G","year":"1994"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.21307\/immunohematology-2019-328"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1999.39111239.x"},{"key":"e_1_2_7_8_2","doi-asserted-by":"crossref","first-page":"138","DOI":"10.21307\/immunohematology-2019-440","article-title":"Rewiew drug\u2010induced immune hemolytic anemia\u2014the last decade","volume":"20","author":"Garratty G","year":"2004","journal-title":"Immunohematology"},{"key":"e_1_2_7_9_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21307\/immunohematology-2019-646","article-title":"In vitro reactions with red blood cells that are not due to blood group antibodies: a review","volume":"14","author":"Garratty G","year":"1998","journal-title":"Immunohematology"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1989.29689318461.x"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1993.33893342753.x"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1351\/pac198961101783"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2004.03378.x"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1423-0410.2002.00188.x"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00615.x"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00262747"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1987.27688071694.x"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(53)90377-5"},{"key":"e_1_2_7_19_2","first-page":"671","volume-title":"Blood platelets","author":"Miescher PA","year":"1961"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-60-3-506"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1537-2995.2008.01797.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1537-2995.2008.01797.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T00:13:12Z","timestamp":1697242392000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1537-2995.2008.01797.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["10.1111\/j.1537-2995.2008.01797.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1537-2995.2008.01797.x","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1131903.589007","asserted-by":"object"}]},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}